Reportstack has announced a new market research publication on Global Gynecological Cancers Market 2014-2018. The following companies are the key players in the Global Gynecological Cancers Market: Becton Dickinson and Co., Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., and GlaxoSmithKline plc. “Personalized medicines have the ability to provide customized treatment to patients, based on patients' genetic and medical profiles. Biomarkers are used in predicting the patient response to a particular drug and they help in identifying the patient population set that is more likely to respond to a particular drug therapy. Personalized medicines are increasingly being used in targeted gynecological cancer therapies. The major market players are increasingly investing in targeted agents and the development of personalized therapies. Though the treatment using personalized medicine is a new concept, advancements in the techniques will drive the growth of the Global Gynecological market.”
According to the report, one of the major drivers in this market is the increase in the prevalence of gynecological cancer. This increase is due to several factors such as obesity, infertility, mutations in specific genes, early start of menstruation, and late start of menopause. The increase in the prevalence of gynecological cancer has encouraged the demand for gynecological cancer drugs.
Further, the report states that one of the main challenges in the market is the increase in use of CAM. CAM is one of the alternative treatments considered by cancer patients. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit http://www.reportstack.com/product/148274/global-gynecological-cancers-market-2014-2018.html
No comments:
Post a Comment